Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neuro-Oncology
Metadata
Title
Acknowledgement of reviewers 2011
Publication date
01-01-2013
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-1003-4

Other articles of this Issue 1/2013

Journal of Neuro-Oncology 1/2013 Go to the issue

Clinical Study

Anaplastic PXA in adults: case series with clinicopathologic and molecular features

Clinical Study

Epilepsy in the end-of-life phase in patients with high-grade gliomas

Letter to the Editor

Outcome of discontinuing bevacizumab prior to malignant glioma progression

Clinical Study

Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema

Clinical Study

Post-treatment T1 shortening in primary CNS lymphoma

Laboratory Investigation

The role of LAT1 in 18F-DOPA uptake in malignant gliomas